Periodontitis
Conditions
Keywords
smoking cessation, tobacco, dental, periodontal
Brief summary
The aim of this prospective study is to verify the efficacy of smoking cessation on non-surgical periodontal therapy in adult subjects with chronic periodontitis. Smokers that were willing to quit received periodontal treatment and concurrent smoking cessation therapy. Periodontal maintenance was performed every 3 months. A calibrated examiner, blinded to smoking status, assessed periodontal status, gathered demographic and behavioural information with a structured questionnaire and measured air carbon monoxide concentration measurements.
Interventions
Multidisciplinary smoking cessation therapy, performed by a team comprising physicians, nurses, a psychologist and dentists. It consisted of four 1-h counselling lectures, psychologist-assisted cognitive behavioural therapy, nicotine replacement therapy and medication (bupropion or varenicline). Smoking cessation motivation was reinforced by dentists at the maintenance sessions, by means of motivational interviewing techniques
full-mouth supra and subgingival scaling and root planing (with curettes and ultrasonic scaler); oral hygiene instruction and motivation and removal of intra-oral plaque retentive factors
Sponsors
Study design
Eligibility
Inclusion criteria
* subjects were willing to stop smoking * \>10 teeth * periodontitis (30% or more of their teeth with proximal CAL ≥ 5 mm
Exclusion criteria
* systemic conditions considered as risk factors for periodontal disease, * periodontal therapy in the last 6 months * continuous systemic use of anti-inflammatory or steroidal drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Clinical Attachment Level (millimeters) after 24 months | baseline and 24 months |
Secondary
| Measure | Time frame |
|---|---|
| Change in Gingival recession (millimeters) after 24 months | baseline and 24 months |
| Change in Pocket depth (millimeters) after 24 months | baseline and 24 months |
| Change in bleeding on probing (percentage of sites with bleeding) after 24 months | baseline and 24 months |
| Change in visible plaque (percentage of sites with visible plaque) after 24 months | baseline and 24 months |